It is now highly recognized that AD is a multifactorial disease and yet, at present most therapeutic approaches have focused on single target such as elimination of Tau and amyloid accumulation in the brain, with only a small amount of success for long term reversal of cognitive dysfunction [54–57]. The gene discussed is MAPT; the disease is Alzheimer disease.